Business Description
Wakamoto Pharmaceutical Co Ltd
ISIN : JP3991200001
Description
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 36.18 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.63 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.76 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.5 | |||||
| 3-Year EPS without NRI Growth Rate | 42.6 | |||||
| 3-Year FCF Growth Rate | -30.1 | |||||
| 3-Year Book Growth Rate | 1.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.81 | |||||
| 9-Day RSI | 38.84 | |||||
| 14-Day RSI | 41.4 | |||||
| 6-1 Month Momentum % | -7.36 | |||||
| 12-1 Month Momentum % | 24.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | |||||
| Quick Ratio | 3.48 | |||||
| Cash Ratio | 2.02 | |||||
| Days Inventory | 181.06 | |||||
| Days Sales Outstanding | 120.96 | |||||
| Days Payable | 78.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.31 | |||||
| Dividend Payout Ratio | 0.96 | |||||
| Forward Dividend Yield % | 2.62 | |||||
| 5-Year Yield-on-Cost % | 1.31 | |||||
| Shareholder Yield % | 1.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.52 | |||||
| Operating Margin % | -2.53 | |||||
| Net Margin % | 1.41 | |||||
| FCF Margin % | -9.07 | |||||
| ROE % | 0.91 | |||||
| ROA % | 0.71 | |||||
| ROIC % | -1.24 | |||||
| ROC (Joel Greenblatt) % | 2.53 | |||||
| ROCE % | 1.18 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 72 | |||||
| PS Ratio | 1.01 | |||||
| PB Ratio | 0.66 | |||||
| Price-to-Tangible-Book | 0.67 | |||||
| EV-to-EBIT | 27.79 | |||||
| EV-to-EBITDA | 27.79 | |||||
| EV-to-Revenue | 0.57 | |||||
| EV-to-FCF | -6.31 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Median-PS-Value | 2.07 | |||||
| Price-to-Net-Current-Asset-Value | 1.54 | |||||
| Price-to-Net-Cash | 25.37 | |||||
| Earnings Yield (Greenblatt) % | 3.6 | |||||
| FCF Yield % | -8.83 | |||||
| Forward Rate of Return (Yacktman) % | -26.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wakamoto Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 7,738.425 | ||
| EPS (TTM) (円) | 3.125 | ||
| Beta | 0.05 | ||
| Volatility % | 22.81 | ||
| 14-Day RSI | 41.4 | ||
| 14-Day ATR (円) | 4.794674 | ||
| 20-Day SMA (円) | 233.95 | ||
| 12-1 Month Momentum % | 24.48 | ||
| 52-Week Range (円) | 197 - 324 | ||
| Shares Outstanding (Mil) | 34.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wakamoto Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wakamoto Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wakamoto Pharmaceutical Co Ltd Frequently Asked Questions
What is Wakamoto Pharmaceutical Co Ltd(TSE:4512)'s stock price today?
The current price of TSE:4512 is 円225.00. The 52 week high of TSE:4512 is 円324.00 and 52 week low is 円197.00.
When is next earnings date of Wakamoto Pharmaceutical Co Ltd(TSE:4512)?
The next earnings date of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is .
Does Wakamoto Pharmaceutical Co Ltd(TSE:4512) pay dividends? If so, how much?
The Dividend Yield %  of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is 1.31% (As of Today), Highest Dividend Payout Ratio of Wakamoto Pharmaceutical Co Ltd(TSE:4512) was 5.28. The lowest was 0.79. And the median was 1.09. The  Forward Dividend Yield % of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is 2.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers